Impact of mono‐ or multitherapy on ocular surface health and quality of life after 5 years of follow‐up in the Glaucoma Intensive Treatment Study (GITS)
We found no differences in objective or subjective impact on ocular surface between the two randomization arms. However, a subgroup of glaucoma patients had more severe OSD irrespective of the amount of topical glaucoma treatment received, and this should be considered when choosing glaucoma therapy treatment in this subgroup by considering laser treatment or non-preserved eye drops.
Authors
- Johan Aspberg (ORCID: https://orcid.org/0000-0001-9707-9509)
- Anders Heijl (ORCID: https://orcid.org/0000-0001-7233-6919)
- Sabina Andersson‐Geimer (ORCID: https://orcid.org/0000-0003-2703-7092)
- Boel Bengtsson (ORCID: https://orcid.org/0000-0002-5997-3953)
- Dorothea Peters (ORCID: https://orcid.org/0000-0001-8062-2026)
- Gauti Jóhannesson (ORCID: https://orcid.org/0000-0003-0218-4563)
- Christina Lindén
Institutions
- University of Iceland (IS)
- Lund University (SE)
- Karolinska Institutet (SE)
- S:t Eriks Ögonsjukhus (SE)
- Skåne University Hospital (SE)
- Umeå University (SE)
Publication Details
- Journal
- Acta Ophthalmologica
- Published
- 2026-01-29
- DOI
- https://doi.org/10.1111/aos.70078
- Primary Topic
- Ocular Surface and Contact Lens
- Type
- article
- Field-Weighted Citation Impact
- 0.00